188 related articles for article (PubMed ID: 2837852)
21. [Relation of neopterin and beta 2 microglobulin to disease activity in chronic polyarthritis].
Ulreich A; Rainer F; Sedlmayr P; Leb G
Acta Med Austriaca; 1988; 15(5):145-8. PubMed ID: 3064525
[TBL] [Abstract][Full Text] [Related]
22. The neopterin/creatinine ratio cannot be used to diagnose rejection episodes in renal transplant recipients.
Bäckman L; Ringdén O
Nephron; 1989; 53(3):287. PubMed ID: 2797354
[No Abstract] [Full Text] [Related]
23. Serum beta 2-microglobulin before and after renal and heart allotransplantation and in infection.
Korcáková L; Svobodová J; Sedlácková E; Kaslík J; Kaslíková J; Horák J; Fabián J; Kocandrle V
Czech Med; 1989; 12(3):158-61. PubMed ID: 2553359
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of combination of biologic markers (C-reactive protein, neopterin, and microalbuminuria) in the follow-up of kidney transplantation in children: four years of clinical experience.
Fischbach M; Desprez P; Mengus L; Christman D; Marcellin L; Chenard MP; Hamel G; Koehl C; Simeoni U; Boudjema K
Transplant Proc; 1994 Feb; 26(1):72-4. PubMed ID: 8109029
[No Abstract] [Full Text] [Related]
25. Monitoring of serum neopterin levels for diagnosis of acute rejection of renal allografts.
Reibnegger G; Fuchs D; Hausen A; Werner ER; Werner-Felmayer G; Wachter H
Nephron; 1989; 52(1):100. PubMed ID: 2651945
[No Abstract] [Full Text] [Related]
26. A preliminary study on the significant value of beta-2-microglobulin over serum creatinine in renal transplant rejection and renal failure.
Sonkar GK; Usha ; Singh RG
Singapore Med J; 2008 Oct; 49(10):786-9. PubMed ID: 18946611
[TBL] [Abstract][Full Text] [Related]
27. Serum alpha-1 microglobulin levels as indicators of renal function in allograft recipients.
Duraj F; Bäckman L; Dati F; Ringdén O
Transplant Proc; 1989 Feb; 21(1 Pt 2):1871-2. PubMed ID: 2469229
[No Abstract] [Full Text] [Related]
28. Interferon-gamma, neopterin, and interleukin-2 receptor levels in the serum of kidney transplant recipients.
Steiner G; Zlabinger G; Karamehic J; Pohanka E; Kovarik J; Woloszczuk W
Transplant Proc; 1990 Aug; 22(4):1857-8. PubMed ID: 2117813
[No Abstract] [Full Text] [Related]
29. Monitoring of serum neopterin in renal transplant recipients.
Lee PH; Huang MT; Chung YC; Hu RH; Tzeng SS; Lee CJ; Lee CS
J Formos Med Assoc; 1992 Dec; 91(12):1209-12. PubMed ID: 1363646
[TBL] [Abstract][Full Text] [Related]
30. The impact of cyclosporine on the practice of renal transplantation.
Kahan BD
Transplant Proc; 1989 Jun; 21(3 Suppl 1):63-9. PubMed ID: 2545019
[No Abstract] [Full Text] [Related]
31. Posttransplant neopterin excretion in renal allograft recipients--a reliable diagnostic aid for acute rejection and a predictive marker of long-term graft survival.
Reibnegger G; Aichberger C; Fuchs D; Hausen A; Spielberger M; Werner ER; Margreiter R; Wachtehr H
Transplantation; 1991 Jul; 52(1):58-63. PubMed ID: 1858155
[TBL] [Abstract][Full Text] [Related]
32. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients.
Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904
[No Abstract] [Full Text] [Related]
33. beta-2-microglobulin. Quantitation by rocket immunoelectrophoresis and evaluation of serum levels in renal transplant patients.
Barnes RM; Alexander LC
Transplantation; 1983 Jun; 35(6):552-5. PubMed ID: 6191415
[TBL] [Abstract][Full Text] [Related]
34. Beta 2 microglobulin after renal transplantation.
Schweizer RT; Bourassa C; Hayden J; Moore R; Bartus SA
Proc Clin Dial Transplant Forum; 1980; 10():255-7. PubMed ID: 6180430
[No Abstract] [Full Text] [Related]
35. The free fraction of cyclosporine in plasma: clinical findings with a new method.
Lindholm A; Henricsson S; Gang P
Transplant Proc; 1988 Apr; 20(2 Suppl 2):377-81. PubMed ID: 2834841
[No Abstract] [Full Text] [Related]
36. Beta-2-microglobulin, neopterin and monocyte Fc gamma receptors in opportunistic infections of HIV-positive patients.
Dunne J; Feighery C; Whelan A
Br J Biomed Sci; 1996 Dec; 53(4):263-9. PubMed ID: 9069103
[TBL] [Abstract][Full Text] [Related]
37. Beta-2-microglobulin for differentiation between ciclosporin A nephrotoxicity and graft rejection in renal transplant recipients.
Prischl F; Gremmel F; Schwabe M; Schindler J; Balcke P; Kopsa H; Pinter G; Schwarzmeier J; Zazgornik J
Nephron; 1989; 51(3):330-7. PubMed ID: 2645532
[TBL] [Abstract][Full Text] [Related]
38. Value of circulating immune parameters in renal transplantation.
Rebhandl W; Felberbauer FX; Resch S; Paya K; Schneider B; Riegler-Keil M; Mühlbacher F; Stockenhuber F
Transplant Proc; 1997 May; 29(3):1881-5. PubMed ID: 9142311
[No Abstract] [Full Text] [Related]
39. Occurrence of cytomegalovirus infection and factors causing reactivation of the infection among renal transplant recipients: a single center study.
Khameneh ZR
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):41-5. PubMed ID: 18087121
[TBL] [Abstract][Full Text] [Related]
40. Fetal serum concentrations of cystatin C and beta2-microglobulin as predictors of postnatal kidney function.
Bökenkamp A; Dieterich C; Dressler F; Mühlhaus K; Gembruch U; Bald R; Kirschstein M
Am J Obstet Gynecol; 2001 Aug; 185(2):468-75. PubMed ID: 11518911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
